array:23 [ "pii" => "S217357430970139X" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70139-X" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70139" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "copyrightAnyo" => "2009" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2009;5:291" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 498 "formatos" => array:3 [ "EPUB" => 37 "HTML" => 338 "PDF" => 123 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574309701406" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70140-6" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70140" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2009;5:292-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 527 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 321 "PDF" => 164 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Response of the author to the letter “Cost-effectiveness study of leflunomide versus methotrexate”" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "292" "paginaFinal" => "293" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta del autor a la carta «Estudio coste-efectividad de leflunomida frente a metrotexato»" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio J. García Ruiz, Ana C. Montesinos Gálvez, Lucía Pérez Costillas, Pablo Rebollo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Antonio J." "apellidos" => "García Ruiz" ] 1 => array:2 [ "nombre" => "Ana C." "apellidos" => "Montesinos Gálvez" ] 2 => array:2 [ "nombre" => "Lucía Pérez" "apellidos" => "Costillas" ] 3 => array:2 [ "nombre" => "Pablo" "apellidos" => "Rebollo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701406?idApp=UINPBA00004M" "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701406/v1_201305061600/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173574309701388" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70138-8" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70138" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 0 "subdocumento" => "sco" "cita" => "Reumatol Clin. 2009;5:289-90" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2324 "formatos" => array:3 [ "EPUB" => 38 "HTML" => 1311 "PDF" => 975 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Massive pleural effusion in systemic lupus erythematosus" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "289" "paginaFinal" => "290" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Derrame pleural masivo en lupus erimematoso sistémico" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mireya Elizabeth González Leija, Mauricio Orrantia Vertiz, Miguel Á. Vázquez Zaragoza" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Mireya Elizabeth" "apellidos" => "González Leija" ] 1 => array:2 [ "nombre" => "Mauricio" "apellidos" => "Orrantia Vertiz" ] 2 => array:2 [ "nombre" => "Miguel Á." "apellidos" => "Vázquez Zaragoza" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701388?idApp=UINPBA00004M" "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701388/v1_201305061600/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Cost-effectiveness study of leflunomide versus methotrexate" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "291" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Jordi Galván" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Jordi" "apellidos" => "Galván" "email" => array:1 [ 0 => "jordi.galvan@gebro.es" ] ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Departamento Médico, Laboratorios GEBRO PHARMA S.A., Barcelona, Spain" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio coste-efectividad de leflunomida frente a metotrexato" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparación de leflunomida y metotrexato subcutáneo en el tratamiento de la artritis reumatoide: una aproximación basada en el número de pacientes que es necesario tratar" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.A. García Ruiz" 1 => "A.C. Montesinos Gálvez" 2 => "L. Pérez Costillas" 3 => "P. Rebollo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2008.11.007" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2009" "volumen" => "5" "paginaInicial" => "66" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794646" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Strand" 1 => "S. Cohen" 2 => "M. Schiff" 3 => "A. Weaver" 4 => "R. Fleischmann" 5 => "G. Cannon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1999" "volumen" => "159" "paginaInicial" => "2542" "paginaFinal" => "2550" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10573044" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Braun" 1 => "P. Kästner" 2 => "P. Flaxenberg" 3 => "J. Währisch" 4 => "P. Hanke" 5 => "W. Demary" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.23144" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2008" "volumen" => "58" "paginaInicial" => "73" "paginaFinal" => "81" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18163521" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Sociedad Española de Reumatología (SER). Actualización de la guía de práctica clínica para el manejo de la artritis reumatoide en España. 2007 [cited Jun 2009]. Available from: URL: <a class="elsevierStyleInterRef" href="http://www.ser.es/">www.ser.es</a>." ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: An evaluation based on a 1-year randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Maetzel" 1 => "V. Strand" 2 => "P. Tugwell" 3 => "G. Wells" 4 => "C. Bombardier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacoeconomics" "fecha" => "2002" "volumen" => "20" "paginaInicial" => "61" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11817993" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análisis farmacoeconómico de Metoject<span class="elsevierStyleSup">®</span> en el tratamiento de la artritis reumatoide en España. XXXIV congreso Nacional de la SER. La Coruña, Mayo 2008" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Crespo" 1 => "M. Brosa" 2 => "J. Galván" 3 => "J. Carbonell" 4 => "J. Maymó" 5 => "J.L. Marenco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1699-258X(08)76163-1" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2008" "volumen" => "4" "numero" => "Suppl 2" "paginaInicial" => "18" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794559" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "¿Qué es una tecnología sanitaria eficiente en España?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.A. Sacristán" 1 => "J. Oliva" 2 => "J. del Llano" 3 => "L. Prieto" 4 => "J.L. Pinto" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gac San" "fecha" => "2002" "volumen" => "16" "paginaInicial" => "334" "paginaFinal" => "343" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Base de datos del medicamento. Colegio Oficial de Farmacéuticos. 2009 [cited Jun 2009]. Available from: URL: <a class="elsevierStyleInterRef" href="http://www.portalfarma.com/">http://www.portalfarma.com</a>." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000000500000006/v1_201305061600/S217357430970139X/v1_201305061600/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000500000006/v1_201305061600/S217357430970139X/v1_201305061600/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357430970139X?idApp=UINPBA00004M" ]
Journal Information
Vol. 5. Issue 6.
Pages 291 (November - December 2009)
Vol. 5. Issue 6.
Pages 291 (November - December 2009)
Full text access
Cost-effectiveness study of leflunomide versus methotrexate
Estudio coste-efectividad de leflunomida frente a metotrexato
Visits
3435
Jordi Galván
Departamento Médico, Laboratorios GEBRO PHARMA S.A., Barcelona, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
J.A. García Ruiz, A.C. Montesinos Gálvez, L. Pérez Costillas, P. Rebollo.
Comparación de leflunomida y metotrexato subcutáneo en el tratamiento de la artritis reumatoide: una aproximación basada en el número de pacientes que es necesario tratar.
Reumatol Clin, 5 (2009), pp. 66-70
[2.]
V. Strand, S. Cohen, M. Schiff, A. Weaver, R. Fleischmann, G. Cannon, et al.
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
Arch Intern Med, 159 (1999), pp. 2542-2550
[3.]
J. Braun, P. Kästner, P. Flaxenberg, J. Währisch, P. Hanke, W. Demary, et al.
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Arthritis Rheum, 58 (2008), pp. 73-81
[4.]
Sociedad Española de Reumatología (SER). Actualización de la guía de práctica clínica para el manejo de la artritis reumatoide en España. 2007 [cited Jun 2009]. Available from: URL: www.ser.es.
[5.]
A. Maetzel, V. Strand, P. Tugwell, G. Wells, C. Bombardier.
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: An evaluation based on a 1-year randomised controlled trial.
Pharmacoeconomics, 20 (2002), pp. 61-70
[6.]
C. Crespo, M. Brosa, J. Galván, J. Carbonell, J. Maymó, J.L. Marenco, et al.
Análisis farmacoeconómico de Metoject® en el tratamiento de la artritis reumatoide en España. XXXIV congreso Nacional de la SER. La Coruña, Mayo 2008.
Reumatol Clin, 4 (2008), pp. 18
[7.]
J.A. Sacristán, J. Oliva, J. del Llano, L. Prieto, J.L. Pinto.
¿Qué es una tecnología sanitaria eficiente en España?.
Gac San, 16 (2002), pp. 334-343
[8.]
Base de datos del medicamento. Colegio Oficial de Farmacéuticos. 2009 [cited Jun 2009]. Available from: URL: http://www.portalfarma.com.
Copyright © 2009. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología